Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
REGN

Regeneron

$371.83

9.96 (2.75%)

07:02
08/17/18
08/17
07:02
08/17/18
07:02
Hot Stocks
Regeneron: FDA approves sBLA for EYLEA Injection in patients with wet AMD »

Regeneron Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 20

    Oct

  • 28

    Oct

Thursday
REGN

Regeneron

$361.87

-4.48 (-1.22%)

, TEVA

Teva

$22.47

0.35 (1.58%)

09:21
08/16/18
08/16
09:21
08/16/18
09:21
Recommendations
Regeneron, Teva analyst commentary at Piper Jaffray »

Regeneron's…

REGN

Regeneron

$361.87

-4.48 (-1.22%)

TEVA

Teva

$22.47

0.35 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 12

    Sep

  • 16

    Sep

  • 20

    Oct

  • 28

    Oct

TEVA

Teva

$22.47

0.35 (1.58%)

, REGN

Regeneron

$361.87

-4.48 (-1.22%)

07:04
08/16/18
08/16
07:04
08/16/18
07:04
Hot Stocks
Teva, Regeneron announce Phase 3 fasinumab study met co-primary endpoints »

Teva Pharmaceutical…

TEVA

Teva

$22.47

0.35 (1.58%)

REGN

Regeneron

$361.87

-4.48 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 12

    Sep

  • 16

    Sep

  • 20

    Oct

  • 28

    Oct

REGN

Regeneron

$361.87

-4.48 (-1.22%)

, TEVA

Teva

$22.47

0.35 (1.58%)

07:02
08/16/18
08/16
07:02
08/16/18
07:02
Hot Stocks
Regeneron, Teva announce 'positive' topline Phase 3 fasinumab results »

Regeneron (REGN) and Teva…

REGN

Regeneron

$361.87

-4.48 (-1.22%)

TEVA

Teva

$22.47

0.35 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 12

    Sep

  • 16

    Sep

  • 20

    Oct

  • 28

    Oct

Over a week ago
REGN

Regeneron

$368.77

-3.55 (-0.95%)

, NVS

Novartis

$82.12

-1.14 (-1.37%)

09:38
08/13/18
08/13
09:38
08/13/18
09:38
Recommendations
Regeneron, Novartis analyst commentary at Piper Jaffray »

Regeneron should be…

REGN

Regeneron

$368.77

-3.55 (-0.95%)

NVS

Novartis

$82.12

-1.14 (-1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

  • 27

    Aug

  • 20

    Oct

  • 28

    Oct

REGN

Regeneron

$368.77

-3.55 (-0.95%)

07:09
08/13/18
08/13
07:09
08/13/18
07:09
Hot Stocks
Regeneron: FDA issues CRL regarding sBLA for EYLEA Injection »

Regeneron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 28

    Oct

AAPL

Apple

$207.56

-0.66 (-0.32%)

, DDAIF

Daimler AG

$0.00

(0.00%)

10:28
08/11/18
08/11
10:28
08/11/18
10:28
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$207.56

-0.66 (-0.32%)

DDAIF

Daimler AG

$0.00

(0.00%)

X

U.S. Steel

$29.96

-0.29 (-0.96%)

AKS

AK Steel

$4.31

-0.06 (-1.37%)

NUE

Nucor

$63.48

0.07 (0.11%)

STLD

Steel Dynamics

$43.54

-0.77 (-1.74%)

AA

Alcoa

$45.01

1.99 (4.63%)

CENX

Century Aluminum

$12.15

0.01 (0.08%)

CLF

Cleveland-Cliffs

$10.32

0.09 (0.88%)

REGN

Regeneron

$368.77

-3.55 (-0.95%)

AMGN

Amgen

$194.43

0.5 (0.26%)

RHHBY

Roche

$0.00

(0.00%)

JNJ

Johnson & Johnson

$130.75

-0.45 (-0.34%)

BA

Boeing

$339.42

-4.3 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Aug

  • 14

    Aug

  • 25

    Aug

  • 11

    Sep

  • 20

    Oct

  • 28

    Oct

  • 09

    Nov

REGN

Regeneron

$372.79

-18.73 (-4.78%)

12:30
08/08/18
08/08
12:30
08/08/18
12:30
Recommendations
Regeneron analyst commentary at Piper Jaffray »

Piper says CMS Part B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Aug

  • 20

    Oct

  • 28

    Oct

REGN

Regeneron

$371.50

-20.02 (-5.11%)

, AMGN

Amgen

$195.59

-4.84 (-2.41%)

10:26
08/08/18
08/08
10:26
08/08/18
10:26
Hot Stocks
Drugmakers fall after CMS unveils changes to Medicare Part B plans »

On Tuesday, the Centers…

REGN

Regeneron

$371.50

-20.02 (-5.11%)

AMGN

Amgen

$195.59

-4.84 (-2.41%)

RHHBY

Roche

$0.00

(0.00%)

JNJ

Johnson & Johnson

$131.03

-0.41 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 11

    Aug

  • 14

    Aug

  • 25

    Aug

  • 20

    Oct

  • 28

    Oct

  • 09

    Nov

REGN

Regeneron

$376.06

-15.46 (-3.95%)

, AMGN

Amgen

$196.51

-3.92 (-1.96%)

09:57
08/08/18
08/08
09:57
08/08/18
09:57
Recommendations
Regeneron, Amgen analyst commentary at Leerink »

Regeneron, Amgen most…

REGN

Regeneron

$376.06

-15.46 (-3.95%)

AMGN

Amgen

$196.51

-3.92 (-1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 11

    Aug

  • 25

    Aug

  • 20

    Oct

  • 28

    Oct

  • 09

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.